SANTA CLARA, Calif. & MILAN--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE:A) and Eurofins Genomics today announced that Agilent plans to offer custom components and an assembled plasmid service for Agilent’s SureVector next-generation cloning kits through a collaboration with Eurofins. Agilent will also offer a set of catalog components for its leading-edge SureVector cloning kits, enabling the creation of over 1 million different cloning vectors. Agilent has been a leading provider of mole
For more information, please visit
http://www.businesswire.com/news/home/20[...]-Collaborate-Expand-SureVector